These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9712883)
21. Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton. Tijchon E; van Ingen Schenau D; van Opzeeland F; Tirone F; Hoogerbrugge PM; Van Leeuwen FN; Scheijen B PLoS One; 2015; 10(7):e0131481. PubMed ID: 26218146 [TBL] [Abstract][Full Text] [Related]
22. MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. Liu L; Ishihara K; Ichimura T; Fujita N; Hino S; Tomita S; Watanabe S; Saitoh N; Ito T; Nakao M J Biol Chem; 2009 Feb; 284(8):5165-74. PubMed ID: 19106100 [TBL] [Abstract][Full Text] [Related]
23. Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity. Yang X; Morita M; Wang H; Suzuki T; Yang W; Luo Y; Zhao C; Yu Y; Bartlam M; Yamamoto T; Rao Z Nucleic Acids Res; 2008 Dec; 36(21):6872-81. PubMed ID: 18974182 [TBL] [Abstract][Full Text] [Related]
24. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758 [TBL] [Abstract][Full Text] [Related]
25. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML. Kim EJ; Park JS; Um SJ Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772 [TBL] [Abstract][Full Text] [Related]
26. The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Duriez C; Falette N; Audoynaud C; Moyret-Lalle C; Bensaad K; Courtois S; Wang Q; Soussi T; Puisieux A Gene; 2002 Jan; 282(1-2):207-14. PubMed ID: 11814693 [TBL] [Abstract][Full Text] [Related]
27. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486 [TBL] [Abstract][Full Text] [Related]
28. Emerging role of anti-proliferative protein BTG1 and BTG2. Kim SH; Jung IR; Hwang SS BMB Rep; 2022 Aug; 55(8):380-388. PubMed ID: 35880434 [TBL] [Abstract][Full Text] [Related]
29. Mouse CAF1 can function as a processive deadenylase/3'-5'-exonuclease in vitro but in yeast the deadenylase function of CAF1 is not required for mRNA poly(A) removal. Viswanathan P; Ohn T; Chiang YC; Chen J; Denis CL J Biol Chem; 2004 Jun; 279(23):23988-95. PubMed ID: 15044470 [TBL] [Abstract][Full Text] [Related]
30. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation. Stupfler B; Birck C; Séraphin B; Mauxion F Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148 [TBL] [Abstract][Full Text] [Related]
31. B-cell translocation gene 2: expression in the rat ovary and potential association with adenine nucleotide translocase 2 in mitochondria. Park JI; Kim SG; Baek MW; Park TJ; Lim IK; Seo YW; Chun SY Mol Cell Endocrinol; 2013 Mar; 367(1-2):31-40. PubMed ID: 23267836 [TBL] [Abstract][Full Text] [Related]
32. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling. Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835 [TBL] [Abstract][Full Text] [Related]
33. Exogenous insulin promotes the expression of B-cell translocation gene 1 and 2 in chicken pectoralis. Zhao JH; Zhang XL; Gao LG; Guo YJ; Wang ZY; Su CC; Zhang HY; Chen W; Huang YQ Poult Sci; 2022 Jul; 101(7):101875. PubMed ID: 35544956 [TBL] [Abstract][Full Text] [Related]
34. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells. Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139 [TBL] [Abstract][Full Text] [Related]
35. BTG2, its family and its tutor. Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462 [TBL] [Abstract][Full Text] [Related]
36. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Donato LJ; Suh JH; Noy N Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770 [TBL] [Abstract][Full Text] [Related]
38. Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1. Ceccarelli M; Micheli L; D'Andrea G; De Bardi M; Scheijen B; Ciotti M; Leonardi L; Luvisetto S; Tirone F Dev Biol; 2015 Dec; 408(1):109-25. PubMed ID: 26524254 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic human papillomaviruses block expression of the B-cell translocation gene-2 tumor suppressor gene. Cullmann C; Hoppe-Seyler K; Dymalla S; Lohrey C; Scheffner M; Dürst M; Hoppe-Seyler F Int J Cancer; 2009 Nov; 125(9):2014-20. PubMed ID: 19551855 [TBL] [Abstract][Full Text] [Related]
40. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]